-->
Advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is projected to hit the market valuation of US$ 16.01 billion by 2033 at a CAGR of 6.9% during the forecast period 2025–2033.
Digital health in neurology market was valued at US$ 38.9 billion in 2024 and is projected to hit the market valuation of US$ 229.5 billion by 2033 at a CAGR of 21.8% during the forecast period 2025–2033.
Left atrial appendage closure devices market was valued at US$ 1.98 billion in 2024 and is projected to hit the market valuation of US$ 9.40 billion by 2033 at a CAGR of 18.9% during the forecast period 2025–2033.
Organ care products market was valued at US$ 199.20 million in 2024 and is projected to hit the market valuation of US$ 812.12 million by 2033 at a CAGR of 16.90% during the forecast period 2025–2033.
Gynecological devices market was valued at US$ 10.18 billion in 2024 and is projected to hit the market valuation of US$ 20.19 billion by 2033 at a CAGR of 7.90% during the forecast period 2025–2033.
Tissue Factor Pathway Inhibitor (TFPI) ELISA kits market was valued at US$ 148.1 million in 2024 and is projected to hit the market valuation of US$ 301.0 million by 2033 at a CAGR of 8.50% during the forecast period 2025–2033.